BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000897 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 21, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,000
Total Value
$690,847.12
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 17, 2026 | Sale | 8,721 | $69.01 | $601,867.61 | 496,965 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details | |
Director | Common Stock | โ | Sep 17, 2026 | Sale | 1,279 | $69.57 | $88,979.52 | 495,686 | Indirect | By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. | View Details |